M. Alcarazo et al. / Journal of Organometallic Chemistry 690 (2005) 5979–5988
5985
2H), 7.23 (d, J = 7.8 Hz, 4H), 4.29 (s, 3H). 13C NMR
(75 MHz, acetone-d6): d 146.7, 145.8, 145.1, 140.0, 127.1,
122.2, 40.7. Anal. Calc. for C15H15N4I: C, 47.64; H, 4.00;
N, 14.81. Found: C, 47.39; H, 3.91; N, 14.72%.
9d: From 4d and MeOTf, the above general procedure
yielded 9d (3.1 g, 96%) as a white solid. 1H NMR
(300 MHz, acetone-d6): d 10.68 (s, 1H), 9.61 (s, 1H), 5.94
(s, 2H), 4.41 (s, 3H), 2.10 (s, 6H). 13C NMR (75 MHz, ace-
tone-d6): d 145.7, 145.6, 129.6, 107.3, 41.1, 10.6. Anal. Calc.
for C10H13N4F3O3S: C, 36.81; H, 4.02; N, 17.17. Found: C,
36.70; H, 3.90; N, 16.89%.
1.90–1.70 (m, 2H). 13C NMR (75 MHz, CDCl3): d 184.9
(d, JC–Rh = 50.3 Hz), 142.4, 135.9, 129.8, 128.9, 128.5,
98.9 (d,JC–Rh = 7.2 Hz), 98.6 (d, JC–Rh = 7.0 Hz), 71.2
(d,JC–Rh = 14.5 Hz), 68.2 (d, JC–Rh = 14.1 Hz), 60.7, 41.6,
34.3, 31.9, 30.5, 28.2. HRMS m/z Calc. for C25H30N4
ClRh524.1214, found 524.1206. Anal. Calc. for
C25H30N4ClRh: C, 57.21; H, 5.76; N, 10.67. Found: C,
57.09; H, 5.84; N, 10.88%.
13b: From 9b, the above general procedure yielded
188 mg (86%) of 13b as a yellow solid. M.p. 182–184 ꢁC
1
(dec.); H NMR (300 MHz, CDCl3): d 8.02 (s, 1H), 7.28
10d: From 4d and MeI, the above general procedure
yielded crystalline 10d (241 mg, 79%). M.p. 230–130 ꢁC
(t, J = 7.8 Hz, 2H), 6.97 (t, J = 7.2 Hz, 1H), 6.64 (d,
J = 8.4 Hz, 2H), 5.01 (br s, 2H), 4.34 (s, 3H), 3.78 (s,
3H), 3.41 (br s, 1H), 2.76 (br s, 1H), 2.41 (br s, 1H),
2.32–2–20 (m, 2H), 1.93 (br s, 2H), 1.62 (br s, 2H), 1.51
(br s, 1H).13C NMR (75 MHz, CDCl3): d 187.6 (d,
JC–Rh = 50.9 Hz), 149.1, 143.9, 129.8, 126.5, 122.0, 114.1,
99.2 (d, JC–Rh = 7.1 Hz), 70.2 (br s), 68.2 (br s), 44.0,
41.5, 34.2 (br s), 31.9 (br s), 30.0 (br s), 28.2 (br s). HRMS
m/z Calc. for C18H28N4ClRh 434.0745, found 434.0736.
Anal. Calc. for C18H24N4ClRh: C, 49.73; H, 5.56; N,
12.89. Found: C, 49.81; H, 5.50; N, 13.00%.
1
(dec.); H NMR (500 MHz, acetone-d6): d 11.25 (s, 1H),
9.61 (s, 1H), 5.91 (s, 2H), 4.39 (s, 3H), 2.13 (s, 6H). 13C
NMR (75 MHz, acetone-d6): d 146.3, 145.6, 129.4, 107.3,
40.2, 10.7. Anal. Calc. for C9H13N4I: C, 35.54; H, 4.31;
N, 18.42. Found: C, 35.42; H, 4.58; N, 18.22%.
11: From 6 and MeOTf, the above general procedure
1
yielded 11 (302 mg, 89%) as a colorless syrup. H NMR
(500 MHz, acetone-d6): d 10.45 (s, 1H), 9.29 (s, 1H), 7.57
(d, J = 6.5 Hz, 2H), 7.47 (m, 3H), 5.68 (s, 2H), 4.23 (s,
3H). 13C NMR (125 MHz, acetone-d6): d 142.0, 141.9,
132.7, 131.4, 131.2, 129.9, 86.1, 40.6. Anal. Calc. for
C11H12N3OF3S: C, 38.94; H, 3.56; N, 12.38. Found: C,
38.64; H, 3.22; N, 12.47%.
13c: From 9c, the above general procedure yielded
226 mg (91%) of 13c as a yellow solid. M.p. 188–190 ꢁC
1
(dec.); H NMR (400 MHz, CDCl3): d 8.03 (s, 1H), 7.31
(t, J = 7.6 Hz, 4H), 7.20–7.05 (m, 6H), 4.97 (br s, 2H),
4.35 (br s, 3H), 3.43 (br s, 1H), 2.85 (br s, 1H), 2.50–2.40
(m, 1H), 2.34–2.22 (m, 1H), 2.20–2.10 (br s, 1H) 1.94 (br
s, 2H), 1.71 (br s, 2H), 1.48 (br s, 1H).13C NMR
(100 MHz, CDCl3): d 188.3 (d,JC–Rh = 50.1 Hz), 145.3,
143.4, 129.6, 124.7, 120.6, 99.0 (d, JC–Rh = 12.1 Hz), 69.9
(d,JC–Rh = 13.7 Hz), 67.4 (d, JC–Rh = 13.1 Hz), 41.1, 34.4,
31.4, 29.7, 27.7. HRMS Calc. for C23H26N4ClRh
496.0901, found 496.0904. Anal. Calc. for C23H26N4ClRh:
C, 55.60; H, 5.27; N, 11.28. Found: C, 55.82; H, 5.43; N,
11.09%.
3.4. Synthesis of 12
Triazolium salt 4d (1 mmol) was treated with LiBEt3H
as described in the literature [15] to afford triazoline 12
1
(127 mg, 71%) as a colorless syrup. H-RMN (300 MHz,
CDCl3): d 6.84 (s, 1H), 5.72 (s, 2H), 4.43 (s, 2H), 2.83 (s,
3H), 2.21 (s, 6H). 13C-RMN (75 MHz, CDCl3): d 143.1,
128.6, 105.1, 77.6, 43.6, 12.7. HRMS m/z Calc. for
C9H14N4: 178.1219, found: 178.1224.
14c: From 10c, the above general procedure yielded
238 mg (81%) of 14c as a yellow solid. M.p. 216–218 ꢁC
(dec.); 1H NMR (400 MHz, CDCl3): d 8.08 (s, 1H),
7.31 (t, J = 8.0 Hz, 4H), 7.20–7.05 (m, 6H), 5.20 (br s,
2H), 4.25 (s, 3H), 3.62–3.54 (m, 1H), 2.95–2.85 (m,
1H), 2.50–2.20 (m, 2H), 2.15–2.03 (m, 1H), 2.00–1.90
(m, 1H), 1.85–1.53 (m, 2H), 1.62–1.50 (m, 4H), 1.42–
1.30 (m, 1H).13C NMR (100 MHz, CDCl3): d 188.4
(d,JC–Rh = 49.3 Hz), 145.2, 143.5, 129.6, 124.9, 121.0,
96.9 (d, JC–Rh = 9.4 Hz), 96.8 (d, JC–Rh = 10.0 Hz), 73.1
(d, JC–Rh = 14.0 Hz), 71.0 (d, JC–Rh = 13.5 Hz), 41.7,
34.3, 30.8, 30.4, 28.0. Anal. Calc. for C23H26N4IRh: C,
46.96; H, 4.45; N, 9.52. Found: C, 47.12; H, 4.49; N,
9.31%.
3.5. Synthesis of RhCl(COD)[4-(dialkylamino or alkoxy)-
1-methyl-1,2,4-triazol-5-ylidenes] 13a–d, 14c,d and 15:
General procedure
To a suspension of 4-(dialkylamino or alkoxy)-1-
methyl-1,2,4-triazolium salt 9a–d, 10c,d or 11 (0.5 mmol)
and [RhCl(COD)]2 (123 mg, 0.25 mmol) in THF (5 mL)
was added Et3N (76 lL, 0.55 mmol) and the mixture was
stirred for 1 h at room temperature. The solvent was re-
moved in vacuo and the residue was purified by flash chro-
matography (AcOEt-Hex 1:4) to afford products 13a–d,
14c, d and 15. Starting materials, yields, and characteriza-
tion data for these compounds are as follows:
13a: From 9a, the above general procedure yielded
179 mg (64%) of 13a as a yellow solid. 1H NMR
(300 MHz, CDCl3): d 7.48–7.21 (m, 11H), 5.32–5.16 (m,
1H), 5.12–5.00 (m, 1H), 4.72 (d, J = 13.2 Hz, 2H), 4.52
(d, J = 13.2 Hz, 2H), 4.27 (s, 3H), 3.50–3.36 (m, 1H),
3.35–3.20 (m, 1H), 2.70–2.60 (m, 1H), 2.60–2.40 (m, 1H),
2.40–2.20 (m, 2H), 2.20–2.10 (m, 1H), 2.10–2.00 (m, 1H),
13d: From 9d, the above general procedure yielded
197 mg (93%) of 13d as a yellow solid. 1H NMR
(300 MHz, CDCl3): d 7.99 (s, 1H), 5.91 (br s, 2H), 4.98
(br s, 2H), 4.37 (s, 3H), 3.47 (br s, 1H), 3.00 (br s, 1H),
2.40 (br s, 4H), 2.28–2.10 (m, 2H), 1.67 (br s, 8H). 13C
NMR (75 MHz, CDCl3): d 187.3 (d, JC–Rh = 51.8 Hz),
142.7, 130.9, 127.2, 106.3, 105.7, 99.9 (br s), 69.6 (d,